
VRTX Competitors
Vertex Pharmaceuticals Incorporated
$538.60
-$4.02(-0.74%)
62
Overall
60
Value
63
Tech
63
Quality
Market Cap
$136.56B
Volume
750.52K
52W Range
$410.50 - $568.67
Target Price
$589.79
VRTX competitors: GILD, ABBV, JNJ, BMY, MRK. Vertex Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VRTX Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| GILD Gilead Sciences, Inc. | $168.26 | $208.31B | $-0.98 | 1.93% | 68 |
| ABBV AbbVie Inc. | $295.68 | $520.47B | $13.98 | 2.34% | 58 |
| JNJ Johnson & Johnson | $286.77 | $682.52B | $11.12 | 1.84% | 62 |
| BMY Bristol-Myers Squibb Company | $63.65 | $127.39B | $6.44 | 3.96% | 69 |
| MRK Merck & Co., Inc. | $147.46 | $362.27B | $2.78 | 2.31% | 69 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $538.60 | -0.7% | 750.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW